Fundz

HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer

PRIVATEMay 24, 2023

Position

Chief Executive Officer

Company

HuidaGene Therapeutics

Alvin Luk
alvinluk@huidagene.com
ShanghaiBiotechnologyHealth CareGeneticsTherapeutics

Description

HuidaGene Therapeutics , a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, Alvin Luk, Ph.D., M.B.A., C.C.R.A., as Co-Founder, Member of the Board of Directors, and Chief Executive Officer.

Quick answer

HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer (May 24, 2023). HuidaGene Therapeutics is based in Shanghai, Shanghai, China.

Who is the new Chief Executive Officer at HuidaGene Therapeutics?
HuidaGene Therapeutics named Alvin Luk Chief Executive Officer, announced May 24, 2023.
What did HuidaGene Therapeutics announce on May 24, 2023?
HuidaGene Therapeutics , a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, Alvin Luk, Ph.D., M.B.A., C.C.R.A., as Co-Founder, Member of the Board of Directors, and Chief Executive Officer.
What does HuidaGene Therapeutics do?
HuidaGene Biotechnology Co., Ltd (辉大基因) is a global clinical-stage biotechnology company focusing on the discovering, engineering, and developing CRISPR-based gene-editing tools and gene therapies to rewrite the future...
Where is HuidaGene Therapeutics based?
HuidaGene Therapeutics is based in Shanghai, Shanghai, China.
Which similar companies made leadership changes around the same time?
Akamis Bio (July 6, 2023), Sinaptica Therapeutics (May 24, 2023), Cepheid (May 23, 2023) and Phanes Therapeutics (May 30, 2023) also announced leadership changes within 45 days of HuidaGene Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Genetics and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at HuidaGene Therapeutics, and when

A new leader at HuidaGene Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day HuidaGene Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HuidaGene Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HuidaGene Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HuidaGene Therapeutics

Location

Shanghai, Shanghai, China

About

HuidaGene Biotechnology Co., Ltd (辉大基因) is a global clinical-stage biotechnology company focusing on the discovering, engineering, and developing CRISPR-based gene-editing tools and gene therapies to rewrite the future of genomic medicine. Based in Shanghai and New Jersey, HuidaGene is committed to addressing patient's needs globally with various preclinical therapeutic programs covering ophthalmology, otology, myology, and neurology. Company's CRISPR-based therapeutics offer the potential to cure patients with life-threatening conditions by repairing the cause of their disease. We are committed to transform the future of genome-editing medicine.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HuidaGene Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Alvin
Likely contact at this company
••••••••@••••••••

See Alvin's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for HuidaGene Therapeutics's next move

Learn about Strategic plan

HuidaGene Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.